1. Marc,Feldmann 英国 University of Oxford 2010美国科学院院士;2003拉斯克奖 Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19
2. John D,Isaacs 英国 University of Newcastle upon Tyne 1974美国科学院院士 A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia[OSCAR]
3. Swartz，Melody A. 美国 University of Chicago 2020美国医学院院士;2023美国工程院院士 Lymphatic coagulation and neutrophil extracellular traps in lung-draining lymph nodes of COVID-19 de..
4. 周宏灏 中国 中南大学 中国工程院院士 Early Prediction Model for Critical Illness of Hospitalized COVID-19 Patients Based on Machine Learn..
5. 黄璐琦 中国 中国中医科学院 中国工程院院士 Comparing different machine learning techniques for predicting COVID-19 severity
6. 黄璐琦 中国 中国中医科学院 中国工程院院士 Factors Defining the Development of Severe Illness in Patients with COVID-19: A Retrospective Study
7. 黄璐琦 中国 中国中医科学院 中国工程院院士 Chinese Medicine Formula Huashibaidu Granule Early Treatment for Mild COVID-19 Patients: An Unblinde..
8. Vonderheide, Robert H. 美国 University of Pennsylvania 2023美国医学院院士 CD8(+) T cells contribute to survival in patients with COVID-19 and hematologic cancer
9. Jedd D,Wolchok 美国 Memorial Sloan-Kettering Cancer Center 2023美国医学院院士 CD8(+) T cells contribute to survival in patients with COVID-19 and hematologic cancer
10. Atkinson, John P. 美国 Washington University School of Medicine 1996美国医学院院士 The complement system in COVID-19: friend and foe?
11. 钟南山 中国 广州医科大学 中国工程院院士 Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 pati..
12. Miriam Merad 美国 Icahn School of Medicine at Mount Sinai 2020美国科学院院士;2023美国医学院院士 Immunology of COVID-19: Current State of the Science
13. Teixeira, Mauro Martins 巴西 University of Federal MINAS GERAIS Dietary Vitamin D Mitigates Coronavirus-Induced Lung Inflammation and Damage in Mice
14. Cherubini, Antonio 意大利 IRCCS INRCA Neutrophil-to-lymphocyte ratio (NLR) predicts mortality in hospitalized geriatric patients independe..
15. 郑仕中 中国 南京中医药大学 COVID-19-associated liver injury: Adding fuel to the flame
16. Giovanni,Landoni 意大利 University of Vita Salute San Raffaele Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, ..
17. Massimo,Puoti 意大利 ASST Grande Ospedale Metropolitano Niguarda Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, ..
18. Coppola, Nicola 意大利 University of Naples 2 Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, ..
19. Matteo,Bassetti 意大利 University of Genoa Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, ..
20. Robert J,Wilkinson 南非 University of Cape Town Immune interaction between SARS-CoV-2 and Mycobacterium tuberculosis